Rationale and design of the STOP-IMH randomised trial: Safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and... 由 E.C.I. Woelders, B. Yosofi, D.A.M. Peeters, L.S.F. Konijnenberg, C. von Birgelen, J.B. van Rees, S.C.H. van den Oord, A.A.C.M. Heestermans, B.E.P.M. Claessen, N. van Royen, R.J.M. van Geuns, R. Nijveldt, P. Damman

獲取全文